|
1
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar
|
|
2
|
Raimondi S, Maisonneuve P and Lowenfels
AB: Epidemiology of pancreatic cancer: an overview. Nat Rev
Gastroenterol Hepatol. 6:699–708. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang L, Yang GH, Lu XH, Huang ZJ and Li H:
Pancreatic cancer mortality in China (1991–2000). World J
Gastroenterol. 9:1819–1823. 2003.
|
|
4
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar
|
|
5
|
Saif MW: Pancreatic neoplasm in 2011: an
update. JOP. 12:316–321. 2011.PubMed/NCBI
|
|
6
|
Stathis A and Moore MJ: Advanced
pancreatic carcinoma: current treatment and future challenges. Nat
Rev Clin Oncol. 7:163–172. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arends JJ, Sleeboom HP, Leys MB, et al: A
phase II study of raltitrexed and gemcitabine in patients with
advanced pancreatic carcinoma. Br J Cancer. 92:445–448.
2005.PubMed/NCBI
|
|
8
|
Liu P, Cheng H, Roberts TM and Zhao JJ:
Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev
Drug Discov. 8:627–644. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Engelman JA: Targeting PI3K signalling in
cancer: opportunities, challenges and limitations. Nat Rev Cancer.
9:550–562. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Datta SR, Dudek H, Tao X, Masters S, Fu H,
Gotoh Y and Greenberg ME: Akt phosphorylation of BAD couples
survival signals to the cell-intrinsic death machinery. Cell.
91:231–241. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and Gonzalez-Baron M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004.PubMed/NCBI
|
|
12
|
Bondar VM, Sweeney-Gotsch B, Andreeff M,
Mills GB and McConkey DJ: Inhibition of the phosphatidylinositol
3′-kinase-AKT pathway induces apoptosis in pancreatic carcinoma
cells in vitro and in vivo. Mol Cancer Ther.
1:989–997. 2002.
|
|
13
|
Roy SK, Srivastava RK and Shankar S:
Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of
FOXO transcription factor, leading to cell cycle arrest and
apoptosis in pancreatic cancer. J Mol Signal. 5:102010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Surh YJ: More than spice: capsaicin in hot
chili peppers makes tumor cells commit suicide. J Natl Cancer Inst.
94:1263–1265. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Surh YJ, Lee E and Lee JM: Chemoprotective
properties of some pungent ingredients present in red pepper and
ginger. Mutat Res. 402:259–267. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Caterina MJ, Schumacher MA, Tominaga M,
Rosen TA, Levine JD and Julius D: The capsaicin receptor: a
heat-activated ion channel in the pain pathway. Nature.
389:816–824. 1997. View
Article : Google Scholar
|
|
17
|
Hartel M, di Mola FF, Selvaggi F, et al:
Vanilloids in pancreatic cancer: potential for chemotherapy and
pain management. Gut. 55:519–528. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pramanik KC, Boreddy SR and Srivastava SK:
Role of mitochondrial electron transport chain complexes in
capsaicin mediated oxidative stress leading to apoptosis in
pancreatic cancer cells. PLoS One. 6:e201512011. View Article : Google Scholar
|
|
19
|
Amantini C, Ballarini P, Caprodossi S, et
al: Triggering of transient receptor potential vanilloid type 1
(TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of
urothelial cancer cells in an ATM-dependent manner. Carcinogenesis.
30:1320–1329. 2009. View Article : Google Scholar
|
|
20
|
Kim JY, Kim EH, Kim SU, Kwon TK and Choi
KS: Capsaicin sensitizes malignant glioma cells to TRAIL-mediated
apoptosis via DR5 upregulation and survivin downregulation.
Carcinogenesis. 31:367–375. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ito K, Nakazato T, Yamato K, et al:
Induction of apoptosis in leukemic cells by homovanillic acid
derivative, capsaicin, through oxidative stress: implication of
phosphorylation of p53 at Ser-15 residue by reactive oxygen
species. Cancer Res. 64:1071–1078. 2004. View Article : Google Scholar
|
|
22
|
Sanchez AM, Sanchez MG, Malagarie-Cazenave
S, Olea N and Diaz-Laviada I: Induction of apoptosis in prostate
tumor PC-3 cells and inhibition of xenograft prostate tumor growth
by the vanilloid capsaicin. Apoptosis. 11:89–99. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang R, Humphreys I, Sahu RP, Shi Y and
Srivastava SK: In vitro and in vivo induction of
apoptosis by capsaicin in pancreatic cancer cells is mediated
through ROS generation and mitochondrial death pathway. Apoptosis.
13:1465–1478. 2008. View Article : Google Scholar
|
|
24
|
Shin DH, Kim OH, Jun HS and Kang MK:
Inhibitory effect of capsaicin on B16-F10 melanoma cell migration
via the phosphatidylinositol 3-kinase/Akt/Rac1 signal pathway. Exp
Mol Med. 40:486–494. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei WT, Chen H, Wang ZH, et al: Enhanced
antitumor efficacy of gemcitabine by evodiamine on pancreatic
cancer via regulating PI3K/Akt pathway. Int J Biol Sci. 8:1–14.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wei WT, Chen H, Ni ZL, et al: Antitumor
and apoptosis-promoting properties of emodin, an anthraquinone
derivative from Rheum officinale Baill, against pancreatic cancer
in mice via inhibition of Akt activation. Int J Oncol.
39:1381–1390. 2011.
|
|
27
|
Shanmugam MK, Kannaiyan R and Sethi G:
Targeting cell signaling and apoptotic pathways by dietary agents:
role in the prevention and treatment of cancer. Nutr Cancer.
63:161–173. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sarkar FH and Li Y: Using chemopreventive
agents to enhance the efficacy of cancer therapy. Cancer Res.
66:3347–3350. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Degterev A, Boyce M and Yuan J: A decade
of caspases. Oncogene. 22:8543–8567. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hamacher R, Schmid RM, Saur D and
Schneider G: Apoptotic pathways in pancreatic ductal
adenocarcinoma. Mol Cancer. 7:642008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kasibhatla S and Tseng B: Why target
apoptosis in cancer treatment? Mol Cancer Ther. 2:573–580.
2003.PubMed/NCBI
|
|
32
|
Hashimoto T, He Z, Ma WY, Schmid PC, Bode
AM, Yang CS and Dong Z: Caffeine inhibits cell proliferation by
G0/G1 phase arrest in JB6 cells. Cancer Res. 64:3344–3349. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liang J and Slingerland JM: Multiple roles
of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell
Cycle. 2:339–345. 2003. View Article : Google Scholar : PubMed/NCBI
|
